These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8665430)

  • 1. Recent advances in cardiology.
    Forman DE; Gordon PC; Parisi AF
    Med Health R I; 1996 May; 79(5):165-74. PubMed ID: 8665430
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent landmark trials in cardiology.
    Jain P; Bhandari S
    Indian Heart J; 2006; 58(2):172-9. PubMed ID: 18989068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of percutaneous transluminal septal myocardial ablation on refractory paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy.
    Hosokawa Y; Takano H; Ohno T; Takayama M; Takano T
    Angiology; 2008; 59(3):329-34. PubMed ID: 18388103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Summary of the clinical studies reported in the scientific session of the American Heart Association 2005 (Dallas, Texas, USA, 13-16 November 2005)].
    Bermejo J; Segovia J; Alfonso F
    Rev Esp Cardiol; 2006 Feb; 59(2):143-53. PubMed ID: 16540036
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role cardiac surgery in the myocardial revascularization of patients with unstable angina in the era of interventional cardiology].
    Pomar JL
    Rev Esp Cardiol; 1999; 52 Suppl 1():141-7. PubMed ID: 10364823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter ablation of septal hypertrophy: a promising alternative to surgery in hypertrophic obstructive cardiomyopathy.
    Keren A; Banai S
    Isr Med Assoc J; 2002 Feb; 4(2):114-6. PubMed ID: 11875983
    [No Abstract]   [Full Text] [Related]  

  • 7. [The best of arrhythmia in 2006].
    Leenhardt A
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():79-83. PubMed ID: 17405569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservative management of complete heart block complicating percutaneous transluminal septal myocardial ablation for patients with obstructive hypertrophic cardiomyopathy.
    Cheng TO
    Am J Cardiol; 2004 Oct; 94(7):982. PubMed ID: 15464700
    [No Abstract]   [Full Text] [Related]  

  • 9. 'The abrupt no-flow': a no-reflow like phenomenon in hypertrophic cardiomyopathy.
    Kuhn H; Gietzen F; Leuner C
    Eur Heart J; 2002 Jan; 23(1):91-3. PubMed ID: 11741371
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of percutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy on systolic and diastolic left ventricular function assessed by pressure-volume loops.
    Meliga E; Steendijk P; Valgimigli M; Ten Cate FJ; Serruys PW
    Am J Cardiol; 2008 Apr; 101(8):1179-84. PubMed ID: 18394455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Percutaneous transluminal septal ablation with ethanol in hypertrophic obstructive cardiomyopathy: a case report].
    Sakakibara M; Abe S; Fusegawa Y; Nakajima T; Iwata O; Goto S; Shiina Y; Handa S
    J Cardiol; 1999 Jul; 34(1):35-40. PubMed ID: 10422624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specialty under attack: where is cardiac surgery heading?
    Shennib H
    Heart Surg Forum; 2003; 6(5):277-8. PubMed ID: 14721792
    [No Abstract]   [Full Text] [Related]  

  • 13. MR imaging evaluation of regional, remote, and global effects of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Amano Y; Takayama M; Kumita S; Kumazaki T
    J Comput Assist Tomogr; 2007; 31(4):600-4. PubMed ID: 17882040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transluminal septal myocardial ablation: a novel, nonsurgical treatment for symptomatic hypertrophic cardiomyopathy.
    Kar S; Makkar R
    Rev Cardiovasc Med; 2001; 2(2):97-102. PubMed ID: 12439386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiogenic shock: collaboration between cardiac surgery and cardiology subspecialties to bridge to recovery.
    Samuels LE; Holmes EC; Hagan K; Boova RS; Janzer S; Kocovic D
    Ann Thorac Surg; 2007 May; 83(5):1863-4. PubMed ID: 17462415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ablative strategy: a definite treatment for cardiac arrhythmias?].
    Hocini M; Pasquié JL; Jaïs P; Haïssaguerre M
    Rev Prat; 2004 Feb; 54(3):291-7. PubMed ID: 15134237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Update on geriatric cardiology].
    Díaz-Castro O; López-Palop R; Datino T; Martínez-Sellés M
    Rev Esp Cardiol (Engl Ed); 2012 Jan; 65 Suppl 1():91-9. PubMed ID: 22269845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aspects of treatment of hypertrophic obstructive cardiomyopathy with emphasis on the role of percutaneous transluminal ablation of the myocardial septum].
    Veselka J
    Vnitr Lek; 2001 Dec; 47(12):887-91. PubMed ID: 11826555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-surgical myocardial ablation: for hypertrophic obstructive cardiomyopathy.
    Sigwart U
    Cardiologia; 1998 Feb; 43(2):157-61. PubMed ID: 9557371
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interventional cardiology].
    Varenne O; Hemery Y
    Rev Prat; 2008 Sep; 58(14):1549-59. PubMed ID: 18839683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.